ASN: Sickle Cell Trait Linked to Risk of Chronic Kidney Disease

This article originally appeared here.
Share this content:
ASN: Sickle Cell Trait Linked to Risk of Chronic Kidney Disease
ASN: Sickle Cell Trait Linked to Risk of Chronic Kidney Disease

(HealthDay News) -- For African-Americans, sickle cell trait (SCT) is associated with increased risk of chronic kidney disease (CKD), according to a review published online Nov. 13 in the Journal of the American Medical Association. The research was published to coincide with the American Society of Nephrology's Kidney Week 2014, held from Nov. 11 to 16 in Philadelphia.

Rakhi P. Naik, M.D., M.H.S., from Johns Hopkins University in Baltimore, and colleagues examined the correlation between SCT and CKD and albuminuria in self-identified African-Americans. Data were collected from five large prospective studies involving 15,975 self-identified African-Americans (1,248 with SCT [carriers] and 14,727 without SCT [noncarriers]).

The researchers found that, compared with noncarriers, carriers had increased risk of CKD (odds ratio, 1.57; absolute risk difference, 7.6 percent); incident CKD (odds ratio, 1.79; absolute risk difference, 8.5 percent); and decline in estimated glomerular filtration rate (eGFR; odds ratio, 1.32; absolute risk difference, 6.1 percent). There was a correlation between SCT and albuminuria (odds ratio, 1.86; absolute risk difference, 12.6 percent).

"Among African-Americans in these cohorts, the presence of SCT was associated with an increased risk of CKD, decline in eGFR, and albuminuria, compared with noncarriers," the authors write. "These findings suggest that SCT may be associated with the higher risk of kidney disease in African-Americans."

Several authors disclosed financial ties to the pharmaceutical and biotechnology industries.

Abstract
Full Text
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »